Next Generation News and Research

RSS

New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks

A new, $17.8 million grant will ensure USC remains at the forefront of research to protect people from tobacco-related health risks.

25 Sep 2018

Environmentally-induced gene activity influences IQ test performance

Is there a link between differences in IQ test performance and the activity of certain genes? Researchers from Charité - Universitätsmedizin Berlin have shown that modifications in the structure of a specific gene have a negative impact on individual test performance.

25 Sep 2018

CSU chemists may help in making extracorporeal life support devices more effective

Smoke inhalation, pneumonia, and combat-related trauma are just a few causes of acute respiratory distress syndrome - a condition where the lungs fill with fluid, and is too often fatal.

24 Sep 2018

New Zealand teenagers less fit than previous generation, finds study

New Zealand teenagers are less fit and weigh more than their parents were at the same age, new University of Otago research reveals.

24 Sep 2018

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

An international research team, led by scientists from the German Primate Center, the Robert Koch Institute, the Max Planck Institute for Evolutionary Anthropology, McGill University, Masaryk University, the University of Tübingen and the Max Planck Institute for the Science of Human History, has successfully recovered genomes of the bacterium Treponema pallidum, which causes syphilis and yaws in humans, from wild nonhuman primate populations across sub-Saharan Africa.

20 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica announces the treatment of the first patient world-wide to receive CMD-501, an autologous CAR-NKT therapy targeting pediatric neuroblastoma

20 Sep 2018

ALSAM Foundation invests additional $2 million for drug discovery and development projects

The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.

20 Sep 2018

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.

20 Sep 2018

Scientists better understand influenza virus and how it spreads

The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

20 Sep 2018

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion, Inc. signed an 'Incubation' agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.

20 Sep 2018

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy.

19 Sep 2018

Henry Ford Health System receives $600k grant to study genetic makeup of gliomas

Henry Ford Health System's Department of Neurosurgery was awarded a $600,000 grant by the Department of Defense to study the genetic makeup of gliomas, a type of brain cancer, in hope of identifying new therapies.

19 Sep 2018

Potential drugs to treat neurodegenerative diseases garner $3 million grant

A new four-year, $3 million grant will enable Scripps Research scientists to advance compounds that may protect neurons in diseases caused by toxic protein accumulation, including Parkinson's, ALS, Alzheimer's and Creutzfeldt-Jakob disease.

18 Sep 2018

Researchers use CRISPR to identify gene that helps cells resist flavivirus infection

UT Southwestern researchers today report the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection. That nasty class of pathogens includes West Nile virus, dengue fever, Zika virus, and yellow fever.

18 Sep 2018

Children's National and NIAID launch pediatric clinical research partnership

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Children's National Health System, a pediatric academic medical center in Washington, D.C., have launched a clinical research partnership devoted to treating and preventing allergic, immunologic and infectious diseases in children.

17 Sep 2018

Next Generation News and Research

New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks

Environmentally-induced gene activity influences IQ test performance

CSU chemists may help in making extracorporeal life support devices more effective

New Zealand teenagers less fit than previous generation, finds study

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

ALSAM Foundation invests additional $2 million for drug discovery and development projects

UK and European research collaborations receive vote of confidence by three major cancer charities

Scientists better understand influenza virus and how it spreads

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Henry Ford Health System receives $600k grant to study genetic makeup of gliomas

Potential drugs to treat neurodegenerative diseases garner $3 million grant

Researchers use CRISPR to identify gene that helps cells resist flavivirus infection

Children's National and NIAID launch pediatric clinical research partnership

People battling substance use disorders may benefit from meth-relapse prevention compound

The Digital Health Platform That’s Tackling Chronic Health Conditions

New project aims to increase patient willingness to take life-saving oral drugs

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News